Medicine and Dentistry
Neoplasm
100%
Rapamycin
100%
Pexidartinib
100%
Macrophage
100%
Malignant Peripheral Nerve Sheath Tumor
100%
Combination Therapy
100%
Diseases
30%
Phosphotransferase
10%
Phosphotransferase Inhibitor
10%
Mammalian Target of Rapamycin Inhibitor
10%
In Vitro
10%
First-in-Man Study
10%
Cancer Inhibition
10%
Tumor Xenograft
10%
Kinase
10%
Hope
10%
Clinical Trial
10%
Orphan Drug
10%
Biopsy Technique
10%
Adaptive Clinical Trial
10%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Combination Therapy
100%
Pexidartinib
100%
Rapamycin
100%
Malignant Peripheral Nerve Sheath Tumor
100%
Diseases
27%
Phosphotransferase
9%
Cancer Inhibition
9%
Chemotherapy
9%
Clinical Trial
9%
Orphan Drug
9%
Phosphotransferase Inhibitor
9%
Mammalian Target of Rapamycin Inhibitor
9%
Adaptive Clinical Trial
9%
Biochemistry, Genetics and Molecular Biology
Tumor-Associated Macrophage
100%
Macrophage
100%
Kinase
50%
Phosphotransferase
50%
Clinical Trial
25%
Mechanistic Target of Rapamycin
25%
Tumor Progression
25%
Growth Inhibition
25%
Hope
25%
Adaptive Clinical Trial
25%